Over and over again, the military has conducted dangerous biowarfare experiments on Americans
Software Giant SAP Is Spending Money to Make Money
Pfizer Sells Capsugel: Will More Asset Sales Follow?
Can Larry Page Make Google a Good Investment Again?
Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts
The 10 Biggest-Selling Drugs That Are About to Lose Their Patent
Pfizer Joins Other Pharmas in Giving a Cautious Outlook
Inside Wall Street: This Tiny Biotech Has Pfizer as a Big Backer
The Autism Study Fraud's Impact on Scientific Research
J&J Unit to Develop Blood Test to Find Cancer Cells
McKinsey's New Management Guide Also Offers 'Value' to Investors
General Electric to Invest $2 Billion in China
R&D Spending Dipped in 2009 for the First Time in a Decade
Novartis Discontinues Two Drug Development Programs
Despite Howls, Leo Apotheker May Be Just What HP Needs Now
Sanofi-Aventis Inks 10-Year R&D Services Deal with Covance
Obama Pushes His New Stimulus Plan
Obama's Business-Friendly Initiatives Take Aim at Anti-Democrat Sentiment
U.S. R&D Spending Aims to Jump-Start Electric-Car Industry
Merck to Cut 16,000 Workers as Drugmaker Closes 16 Plants, Labs
How Misleading Economic Data Increase Investor Risks
Big pharmas are reaching the tipping point. How can they survive?